33 min listen
The Evolution of Incretins – A Revolution in Diabetes Management?
FromKeeping Current
ratings:
Length:
36 minutes
Released:
Jun 27, 2024
Format:
Podcast episode
Description
The expanding world of glucagon-like peptide-1 (GLP-1) receptor antagonism. What do these developments mean for clinical practice? Credit available for this activity expires: 6/27/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001235?ecd=bdc_podcast_libsyn_mscpedu
Released:
Jun 27, 2024
Format:
Podcast episode
Titles in the series (100)
How Can We Meet the Treatment Needs of Patients With Systemic Sclerosis-Interstitial Lung Disease?: Join Drs Distler and Hoffmann-Vold as they discuss current and emerging treatments for SSc-ILD and their clinical impact --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current